Tuesday Nov 24 | Associated Content
David Beckham Soccer: A Photo Reveals the Pro Has Asthma
How can he be so good and still have asthma? Currently, there is no cure for asthma.
can advair effect bone density?
Are you an asthma suffer? Manage your asthma or COPD with great ideas from people like you.
Severe asthma attacks in kids averted by fluticasone/salmeterol combo
In asthmatic children, treatment with fluticasone plus salmeterol is associated with fewer serious exacerbations and lower medical costs compared to the use of an inhaled corticosteroid plus montelukast.
Eosinophilic esophagitis responds well to swallowed fluticasone
Swallowed fluticasone reduces mucosal eosinophilia and relieves symptoms of eosinophilic esophagitis, according to a meta-analysis presented at the annual meeting of the American College of Allergy, Asthma and Immunology in Miami Beach, Florida.
SkyePharma: flutiform Phase III study complete
SkyePharma Plc, /quotes/comstock/11i!skyef /quotes/comstock/23s!e:skp the London producer of pharmaceuticals using proprietary drug-delivery technologies, said that a partner, Mundipharma International Corp., completed the final Phase III study of flutiform, which is being developed to treat asthma.
Flutiform EU Clinical Trial Successfully Completed
FOR IMMEDIATE RELEASE SkyePharma Announces Successful Completion of FlutiformTM EU Clinical Trial Programme LONDON, UK, 2 November, 2009 - SkyePharma PLC today announces that its development and marketing partner Mundipharma International Corporation Limited has successfully completed the final Phase III clinical study for the European development ...
GlaxoSmithKline and Theravance, Inc. Commence Phase III Horizon...
GlaxoSmithKline and Theravance, Inc. today announced that the first patient has commenced treatment as part of the Phase III programme being undertaken to develop a next-generation combination treatment for patients with chronic obstructive pulmonary disorder , a leading cause of chronic illness and death.
Case of the Month: Attacking Asthma
EMS is called to the house of a 12-year-old male patient in severe respiratory distress.
Asthma, allergies and other respiratory ailments afflict a huge number of American children.
SkyePharma Inc. Says More Tests Needed for Asthma Drug
As previously announced, in June 2009 the FDA gave preliminary notice of some potential review issues which it had identified in its preliminary evaluation of the NDA, which had been accepted for substantive review.
Experts Question Study's Asthma Drug Safety Claim
An author of a new industry-funded study on the safety of a commonly prescribed type of inhaled asthma drug says the findings should be "reassuring" to patients who use them.
Archives Pediatrics/Adolescent
Effects of 2 Inhaled Corticosteroids on Growth
Arch Pediatr Adolesc Med. 2001;155:1248-1254. Objective To compare the long-term effect of treatment with fluticasone propionate or beclomethasone dipropionate on growth in asthmatic children.
There are so many medications out there. We'll tell you what you need to know. i was prescribed spirva by a cardiologist about 3 years ago after finding out my asthma wasn't well controlled and was causing chest pain.
Allergy medications: Know your options
Allergy medications reduce your body's reaction to allergens or block symptom-causing chemicals such as histamine.
Helium helps asthmatics breathe - Research summary
Friday, June 19, 2009 BACKGROUND: According to the American Lung Association, asthma is the most common chronic disorder among children.
Off-Center Fold: An Unusual Pruritic Eruption of the Feet--Quiz Case
REPORT OF A CASE A 36-year-old woman presented with a painful and pruritic eruption on both feet.
SkyePharma Inc. Says FDA May Need More Flutiform Data
SkyePharma PLC today announces that the US Food and Drug Administration has issued a communication in respect of the New Drug Application for its lead development product, FlutiformTM , an investigational treatment for persistent asthma in patients 12 years of age and older.
How Safe Is Your Asthma Medication?
A major allergy and respiratory management company knowingly produced flawed clinical trials of FDA approved drugs currently on the market a Texas physician is charging.
SkyePharma PLC: Flutiform NDA Accepted for Review
Flutiform NDA Accepted for Review LONDON, UK, 22 May 2009 - SkyePharma PLC today announces that the New Drug Application for its lead development product, Flutiform , an investigational treatment for persistent asthma in patients 12 years of age and older, has been accepted for review by the US Food and Drug Administration .
Washington University in St. Louis
Children's characteristics may determine response to asthma drug
May 4, 2009 -- Certain characteristics of preschool-aged children at high risk for asthma could help physicians deliver more personalized and effective treatment.